Feasibility of molecular imaging for cerebrovascular disease and its clinical application

@inproceedings{Okazawa2008FeasibilityOM,
  title={Feasibility of molecular imaging for cerebrovascular disease and its clinical application},
  author={Hidehiko Okazawa and Masato Kobayashi and Tetsuya Tsujikawa and Takashi Kudo and Yasushi Kiyono and Yasuhisa Fujibayashi and Talakad Goolaiah Lohith and Vijay N. Tiwari},
  year={2008}
}
Molecular imaging is a useful method for diagnosis of cerebral ischemic diseases as well as evaluation and monitoring of the effects of various treatments. Cu (II)-diacetyl-bis (N4-methylthiosemicarbazone) (Cu-ATSM) is a promising tracer for hypoxic imaging, which is considered to represent mitochondrial deficiency in cerebral infarction. Imaging of microglial activation using ligands for peripheral benzodiazepine receptors would be useful for evaluation of self-restoration function toward… CONTINUE READING